Summary
This study differentiates Early Onset Depression (EOD) and Late Onset Depression (LOD) in older adults aged 60–80, finding that LOD is associated with significantly greater executive dysfunction, likely linked to prefrontal vascular degeneration. These findings suggest distinct therapeutic pathways: behavioral therapy for EOD and cardiovascular risk management (blood pressure and cholesterol reduction) for LOD, with potential BDNF supplementation as a future intervention.
Key Findings
- Depressed patients (both EOD and LOD, N=41) showed reduced performance across nearly all cognitive domains compared to healthy controls (N=22).
- LOD patients showed significantly more impaired executive functions compared to EOD patients.
- Lower BDNF blood concentrations were found in depressed patients compared to controls.
- Significant correlations were found between depression severity and cognition, depression severity and BDNF levels, and cognition and BDNF levels.
- EOD (N=20) is hypothesized to involve a BDNF-independent early depressive episode sustained by negative feedback loops, while LOD (N=21) is attributed to organic prefrontal vascular degeneration compounded by BDNF reduction.
Categories
Mood & Mental Wellness: Investigates neuropsychological differentiation of early-onset vs. late-onset geriatric depression and the role of BDNF in cognitive and emotional processing.
Dementia & Elder Care: Examines cognitive impairment in older adults (ages 60–80) with depression, relevant to geriatric care and therapeutic optimization.
Author(s)
A Losereit
Related Publications
Mood & Mental Wellness
- The two‐process model of sleep regulation: a reappraisal
- Protecting the melatonin rhythm through circadian healthy light exposure
- Effects of artificial dawn and morning blue light on daytime cognitive performance, well-being, cortisol and melatonin levels
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- The role of daylight for humans: gaps in current knowledge
Dementia & Elder Care
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
- Sleep and circadian rhythms in Parkinson's disease and preclinical models
- Chronobioengineering indoor lighting to enhance facilities for ageing and Alzheimer's disorder
- The clock is ticking. Ageing of the circadian system: from physiology to cell cycle